Cargando…

Time-to-event assessment for the discovery of the proper prognostic value of clinical biomarkers optimized for COVID-19

Detalles Bibliográficos
Autor principal:	Ferreira, José Raniery
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2022
Materias:	Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813569/ https://www.ncbi.nlm.nih.gov/pubmed/35405433 http://dx.doi.org/10.1016/j.clinsp.2022.100009

Ejemplares similares

Proper Authentication of Ancient DNA Is Still Essential
por: Eisenhofer, Raphael, et al.
Publicado: (2018)

Response to “Limited capacity to retain phosphorus in the Baltic proper offshore sediments” by Karlsson and Malmaeus
por: Stigebrandt, Anders
Publicado: (2018)

Science in the time of COVID-19: Reflections on the UK Events Research Programme
por: Marteau, Theresa M., et al.
Publicado: (2022)

Renal artery stenting in the correct patients with atherosclerotic renovascular disease: time for a proper renal and cardiovascular outcome study?
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2022)

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

Values in challenging times: strategic crisis management in the EU
por: Prainsack, Barbara, et al.
Publicado: (2022)

Machine learning for chemical discovery
por: Tkatchenko, Alexandre
Publicado: (2020)

Atrial inflammation and atrial function after cardiac surgery: can we study it properly?
por: Dudink, Elton, et al.
Publicado: (2015)

Discovery and characterization of actionable tumor antigens
por: Ehx, Grégory, et al.
Publicado: (2019)

Opportunities and challenges of using social media big data to assess mental health consequences of the COVID-19 crisis and future major events
por: Tušl, Martin, et al.
Publicado: (2022)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Retrospective on a decade of machine learning for chemical discovery
por: von Lilienfeld, O. Anatole, et al.
Publicado: (2020)

Optimizing the timing of nephrology referral for patients with diabetic kidney disease
por: Martínez-Castelao, Alberto, et al.
Publicado: (2020)

The value of open-source clinical science in pandemic response: lessons from ISARIC
Publicado: (2021)

Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
por: Krishna, Sanjeev, et al.
Publicado: (2022)

Optimizing safety surveillance for COVID-19 vaccines
por: Chandler, Rebecca E.
Publicado: (2020)

Optimism and caution for an inactivated COVID-19 vaccine
por: Rostad, Christina A, et al.
Publicado: (2021)

Deeper, longer phenotyping to accelerate the discovery of the genetic architectures of diseases
por: Kohane, Isaac S
Publicado: (2014)

Bringing nuclear materials discovery and qualification into the 21(st) century
por: Aguiar, Jeffery A., et al.
Publicado: (2020)

Remdesivir for COVID-19 in Europe: will it provide value for money?
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Sudden death in a patient with epilepsy and arterial hypertension: time for re-assessment
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Examining the current standards for genetic discovery and replication in the era of mega-biobanks
por: Huffman, J. E.
Publicado: (2018)

Digital biomarkers: Convergence of digital health technologies and biomarkers
por: Vasudevan, Srikanth, et al.
Publicado: (2022)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Comparing statistical methods in assessing the prognostic effect of biomarker variability on time-to-event clinical outcomes
por: Gao, Feng, et al.
Publicado: (2022)

The elusive biomarker
por: Huntingford, Simone, et al.
Publicado: (2022)

First Brazilian pediatric hospital to adopt 1-hour preoperative fasting time for clear fluids for elective surgeries
por: Cardoso, Priscilla Ferreira Neto, et al.
Publicado: (2021)

The value of vaccine programme impact monitoring during the COVID-19 pandemic
por: Ortiz, Justin R, et al.
Publicado: (2022)

Prognostic value of mean platelet volume in patients after acute coronary syndrome
por: Jakl, Martin, et al.
Publicado: (2015)

Triage in the time of COVID-19
por: Gilbert, Allison, et al.
Publicado: (2022)

Complete Blood Cell Count-Derived Biomarkers and Clinical Studies: Is It Time for New Reporting Criteria? Comment on Anand et al. Utility of Red Cell Distribution Width (RDW) as a Noninvasive Biomarker for the Diagnosis of Acute Appendicitis: A Systematic Review and Meta-Analysis of 5222 Cases. Diagnostics 2022, 12, 1011
por: Frater, John L., et al.
Publicado: (2022)

Margaret Buckingham, discoveries in skeletal and cardiac muscle development, elected to the National Academy of Science
por: Rudnicki, Michael A
Publicado: (2012)

ApoNETosis: discovery of a novel form of neutrophil death with concomitant apoptosis and NETosis
por: Azzouz, Dhia, et al.
Publicado: (2018)

Awake prone positioning in COVID-19: is tummy time ready for prime time?
por: Weatherald, Jason, et al.
Publicado: (2021)

The Value of Originality and Proper Quotation
por: Kim, Jeong Tae
Publicado: (2012)

No time for complacency on COVID-19 in Europe
por: Flahault, Antoine, et al.
Publicado: (2023)

Genetic underpinnings of recovery after stroke: an opportunity for gene discovery, risk stratification, and precision medicine
por: Acosta, Julián N., et al.
Publicado: (2019)

Rad-Bio-App: a discovery environment for biologists to explore spaceflight-related radiation exposures
por: Barker, Richard, et al.
Publicado: (2021)

Optimized expression of alternative oxidase
por: Neuzil, Jiri
Publicado: (2022)

Bioethical principles and values during pandemics
por: Lin, Chin An, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qouebrbn1fjevr5cvjlb9bk2ip